nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Ethynodiol—ESR1—Alzheimer's disease	0.00549	0.702	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.00234	0.299	CrCbGaD
Cyproterone acetate—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00211	0.00267	CcSEcCtD
Cyproterone acetate—Muscular weakness—Donepezil—Alzheimer's disease	0.00211	0.00267	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.0021	0.00266	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00209	0.00265	CcSEcCtD
Cyproterone acetate—Affect lability—Rivastigmine—Alzheimer's disease	0.00209	0.00264	CcSEcCtD
Cyproterone acetate—Migraine—Rivastigmine—Alzheimer's disease	0.00209	0.00264	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—BDNF—Alzheimer's disease	0.00207	0.0102	CbGpPWpGaD
Cyproterone acetate—Asthma—Donepezil—Alzheimer's disease	0.00206	0.00261	CcSEcCtD
Cyproterone acetate—Visual impairment—Galantamine—Alzheimer's disease	0.00205	0.0026	CcSEcCtD
Cyproterone acetate—Mood swings—Memantine—Alzheimer's disease	0.00205	0.0026	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Memantine—Alzheimer's disease	0.00203	0.00257	CcSEcCtD
Cyproterone acetate—Pancreatitis—Donepezil—Alzheimer's disease	0.00202	0.00256	CcSEcCtD
Cyproterone acetate—Sweating increased—Donepezil—Alzheimer's disease	0.00201	0.00255	CcSEcCtD
Cyproterone acetate—Mood swings—Rivastigmine—Alzheimer's disease	0.00201	0.00254	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Memantine—Alzheimer's disease	0.002	0.00253	CcSEcCtD
Cyproterone acetate—Eye disorder—Galantamine—Alzheimer's disease	0.00199	0.00252	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00196	0.00248	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Memantine—Alzheimer's disease	0.00195	0.00247	CcSEcCtD
Cyproterone acetate—Angiopathy—Galantamine—Alzheimer's disease	0.00193	0.00245	CcSEcCtD
Cyproterone acetate—Immune system disorder—Galantamine—Alzheimer's disease	0.00192	0.00244	CcSEcCtD
Cyproterone acetate—Breast disorder—Rivastigmine—Alzheimer's disease	0.00192	0.00243	CcSEcCtD
Cyproterone acetate—Muscular weakness—Memantine—Alzheimer's disease	0.00191	0.00242	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00191	0.00242	CcSEcCtD
Cyproterone acetate—Pollakiuria—Donepezil—Alzheimer's disease	0.00191	0.00241	CcSEcCtD
Cyproterone acetate—Weight increased—Donepezil—Alzheimer's disease	0.00188	0.00238	CcSEcCtD
Cyproterone acetate—Asthma—Memantine—Alzheimer's disease	0.00187	0.00237	CcSEcCtD
Cyproterone acetate—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00187	0.00237	CcSEcCtD
Cyproterone acetate—Mental disorder—Galantamine—Alzheimer's disease	0.00187	0.00236	CcSEcCtD
Cyproterone acetate—Weight decreased—Donepezil—Alzheimer's disease	0.00187	0.00236	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00186	0.00236	CcSEcCtD
Cyproterone acetate—Malnutrition—Galantamine—Alzheimer's disease	0.00185	0.00235	CcSEcCtD
Cyproterone acetate—Pancreatitis—Memantine—Alzheimer's disease	0.00184	0.00233	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CDK5—Alzheimer's disease	0.00183	0.00904	CbGpPWpGaD
Cyproterone acetate—Sweating increased—Memantine—Alzheimer's disease	0.00182	0.00231	CcSEcCtD
Cyproterone acetate—Tension—Galantamine—Alzheimer's disease	0.00182	0.00231	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00181	0.0023	CcSEcCtD
Cyproterone acetate—Renal failure—Donepezil—Alzheimer's disease	0.00181	0.00229	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Donepezil—Alzheimer's disease	0.0018	0.00228	CcSEcCtD
Cyproterone acetate—Pancreatitis—Rivastigmine—Alzheimer's disease	0.0018	0.00228	CcSEcCtD
Cyproterone acetate—Jaundice—Donepezil—Alzheimer's disease	0.00179	0.00227	CcSEcCtD
Cyproterone acetate—Sweating increased—Rivastigmine—Alzheimer's disease	0.00179	0.00226	CcSEcCtD
Cyproterone acetate—Sweating—Donepezil—Alzheimer's disease	0.00176	0.00223	CcSEcCtD
Cyproterone acetate—Haematuria—Donepezil—Alzheimer's disease	0.00175	0.00222	CcSEcCtD
Cyproterone acetate—Pollakiuria—Memantine—Alzheimer's disease	0.00173	0.00219	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—SOD1—Alzheimer's disease	0.00173	0.00854	CbGpPWpGaD
Cyproterone acetate—Erectile dysfunction—Memantine—Alzheimer's disease	0.00173	0.00218	CcSEcCtD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—PTK2B—Alzheimer's disease	0.00172	0.00851	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00172	0.00218	CcSEcCtD
Cyproterone acetate—Anaemia—Galantamine—Alzheimer's disease	0.00171	0.00217	CcSEcCtD
Cyproterone acetate—Weight increased—Memantine—Alzheimer's disease	0.0017	0.00216	CcSEcCtD
Cyproterone acetate—Agitation—Galantamine—Alzheimer's disease	0.0017	0.00216	CcSEcCtD
Cyproterone acetate—Weight decreased—Memantine—Alzheimer's disease	0.00169	0.00215	CcSEcCtD
Cyproterone acetate—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00169	0.00214	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Memantine—Alzheimer's disease	0.00169	0.00214	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00169	0.00214	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—Alzheimer's disease	0.00169	0.00832	CbGpPWpGaD
Cyproterone acetate—Malaise—Galantamine—Alzheimer's disease	0.00167	0.00212	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00167	0.00212	CcSEcCtD
Cyproterone acetate—Weight increased—Rivastigmine—Alzheimer's disease	0.00167	0.00211	CcSEcCtD
Cyproterone acetate—Syncope—Galantamine—Alzheimer's disease	0.00166	0.00211	CcSEcCtD
Cyproterone acetate—Haemoglobin—Donepezil—Alzheimer's disease	0.00166	0.0021	CcSEcCtD
Cyproterone acetate—Weight decreased—Rivastigmine—Alzheimer's disease	0.00166	0.0021	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00165	0.00209	CcSEcCtD
Cyproterone acetate—Hepatitis—Donepezil—Alzheimer's disease	0.00165	0.00209	CcSEcCtD
Cyproterone acetate—Haemorrhage—Donepezil—Alzheimer's disease	0.00165	0.00209	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00165	0.00209	CcSEcCtD
Cyproterone acetate—Renal failure—Memantine—Alzheimer's disease	0.00164	0.00208	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.00164	0.00809	CbGpPWpGaD
Cyproterone acetate—Myocardial infarction—Memantine—Alzheimer's disease	0.00164	0.00207	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Galantamine—Alzheimer's disease	0.00163	0.00206	CcSEcCtD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—Alzheimer's disease	0.00163	0.00804	CbGpPWpGaD
Cyproterone acetate—Cough—Galantamine—Alzheimer's disease	0.00162	0.00205	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00161	0.00204	CcSEcCtD
Cyproterone acetate—Renal failure—Rivastigmine—Alzheimer's disease	0.00161	0.00203	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.0016	0.00203	CcSEcCtD
Cyproterone acetate—Haematuria—Memantine—Alzheimer's disease	0.00159	0.00202	CcSEcCtD
Cyproterone acetate—Visual impairment—Donepezil—Alzheimer's disease	0.00159	0.00202	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00158	0.002	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00158	0.00779	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00157	0.00199	CcSEcCtD
Cyproterone acetate—Sweating—Rivastigmine—Alzheimer's disease	0.00157	0.00198	CcSEcCtD
Cyproterone acetate—Discomfort—Galantamine—Alzheimer's disease	0.00156	0.00198	CcSEcCtD
Cyproterone acetate—Haematuria—Rivastigmine—Alzheimer's disease	0.00156	0.00197	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00155	0.00196	CcSEcCtD
Cyproterone acetate—Haemoglobin—Memantine—Alzheimer's disease	0.00151	0.00191	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.0015	0.00742	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Memantine—Alzheimer's disease	0.0015	0.0019	CcSEcCtD
Cyproterone acetate—Hepatitis—Memantine—Alzheimer's disease	0.0015	0.0019	CcSEcCtD
Cyproterone acetate—Shock—Galantamine—Alzheimer's disease	0.00149	0.00189	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Galantamine—Alzheimer's disease	0.00148	0.00188	CcSEcCtD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00148	0.00732	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00148	0.00188	CcSEcCtD
Cyproterone acetate—Chills—Donepezil—Alzheimer's disease	0.00148	0.00188	CcSEcCtD
Cyproterone acetate—Tachycardia—Galantamine—Alzheimer's disease	0.00148	0.00187	CcSEcCtD
Cyproterone acetate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00147	0.00187	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Memantine—Alzheimer's disease	0.00147	0.00187	CcSEcCtD
Cyproterone acetate—Skin disorder—Galantamine—Alzheimer's disease	0.00147	0.00186	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Alzheimer's disease	0.00147	0.00725	CbGpPWpGaD
Cyproterone acetate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00147	0.00186	CcSEcCtD
Cyproterone acetate—Hepatitis—Rivastigmine—Alzheimer's disease	0.00147	0.00186	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00146	0.00185	CcSEcCtD
Cyproterone acetate—Alopecia—Donepezil—Alzheimer's disease	0.00146	0.00185	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.00146	0.0072	CbGpPWpGaD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARGC1A—Alzheimer's disease	0.00146	0.00719	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.00145	0.00716	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—CREB1—Alzheimer's disease	0.00145	0.00715	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Donepezil—Alzheimer's disease	0.00145	0.00183	CcSEcCtD
Cyproterone acetate—Visual impairment—Memantine—Alzheimer's disease	0.00144	0.00183	CcSEcCtD
Cyproterone acetate—Anorexia—Galantamine—Alzheimer's disease	0.00144	0.00183	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00144	0.00183	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00144	0.0071	CbGpPWpGaD
Cyproterone acetate—Malnutrition—Donepezil—Alzheimer's disease	0.00144	0.00182	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Memantine—Alzheimer's disease	0.00142	0.0018	CcSEcCtD
Cyproterone acetate—Hypotension—Galantamine—Alzheimer's disease	0.00141	0.00179	CcSEcCtD
Cyproterone acetate—Visual impairment—Rivastigmine—Alzheimer's disease	0.00141	0.00179	CcSEcCtD
Cyproterone acetate—Tension—Donepezil—Alzheimer's disease	0.00141	0.00179	CcSEcCtD
Cyproterone acetate—Eye disorder—Memantine—Alzheimer's disease	0.0014	0.00177	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—CREB1—Alzheimer's disease	0.00139	0.00688	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00139	0.00176	CcSEcCtD
Cyproterone acetate—Eye disorder—Rivastigmine—Alzheimer's disease	0.00137	0.00174	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—ESR1—Alzheimer's disease	0.00137	0.00676	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Memantine—Alzheimer's disease	0.00136	0.00172	CcSEcCtD
Cyproterone acetate—Immune system disorder—Memantine—Alzheimer's disease	0.00135	0.00172	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Memantine—Alzheimer's disease	0.00135	0.00171	CcSEcCtD
Cyproterone acetate—Chills—Memantine—Alzheimer's disease	0.00135	0.0017	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00134	0.00662	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00134	0.00662	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Dyspepsia—Galantamine—Alzheimer's disease	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Angiopathy—Rivastigmine—Alzheimer's disease	0.00133	0.00169	CcSEcCtD
Cyproterone acetate—Anaemia—Donepezil—Alzheimer's disease	0.00133	0.00168	CcSEcCtD
Cyproterone acetate—Alopecia—Memantine—Alzheimer's disease	0.00132	0.00168	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00132	0.00167	CcSEcCtD
Cyproterone acetate—Agitation—Donepezil—Alzheimer's disease	0.00132	0.00167	CcSEcCtD
Cyproterone acetate—Chills—Rivastigmine—Alzheimer's disease	0.00132	0.00167	CcSEcCtD
Cyproterone acetate—Decreased appetite—Galantamine—Alzheimer's disease	0.00132	0.00167	CcSEcCtD
Cyproterone acetate—Mental disorder—Memantine—Alzheimer's disease	0.00131	0.00166	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00131	0.00166	CcSEcCtD
Cyproterone acetate—Malnutrition—Memantine—Alzheimer's disease	0.00131	0.00165	CcSEcCtD
Cyproterone acetate—Fatigue—Galantamine—Alzheimer's disease	0.00131	0.00165	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.0013	0.00642	CbGpPWpGaD
Cyproterone acetate—Malaise—Donepezil—Alzheimer's disease	0.0013	0.00164	CcSEcCtD
Cyproterone acetate—Alopecia—Rivastigmine—Alzheimer's disease	0.0013	0.00164	CcSEcCtD
Cyproterone acetate—Constipation—Galantamine—Alzheimer's disease	0.00129	0.00164	CcSEcCtD
Cyproterone acetate—Syncope—Donepezil—Alzheimer's disease	0.00129	0.00163	CcSEcCtD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—MEF2C—Alzheimer's disease	0.00129	0.00635	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Rivastigmine—Alzheimer's disease	0.00129	0.00163	CcSEcCtD
Cyproterone acetate—Tension—Memantine—Alzheimer's disease	0.00128	0.00162	CcSEcCtD
Cyproterone acetate—Malnutrition—Rivastigmine—Alzheimer's disease	0.00128	0.00162	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Donepezil—Alzheimer's disease	0.00126	0.0016	CcSEcCtD
Cyproterone acetate—Cough—Donepezil—Alzheimer's disease	0.00125	0.00159	CcSEcCtD
Cyproterone acetate—Tension—Rivastigmine—Alzheimer's disease	0.00125	0.00159	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptors—PPARG—Alzheimer's disease	0.00125	0.00617	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Galantamine—Alzheimer's disease	0.00125	0.00158	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.00124	0.00613	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00124	0.00157	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—ESR1—Alzheimer's disease	0.00122	0.00602	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.00122	0.00601	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Memantine—Alzheimer's disease	0.00121	0.00153	CcSEcCtD
Cyproterone acetate—Discomfort—Donepezil—Alzheimer's disease	0.00121	0.00153	CcSEcCtD
Cyproterone acetate—Anaemia—Memantine—Alzheimer's disease	0.00121	0.00153	CcSEcCtD
Cyproterone acetate—Agitation—Memantine—Alzheimer's disease	0.0012	0.00152	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.0012	0.00591	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Galantamine—Alzheimer's disease	0.0012	0.00152	CcSEcCtD
Cyproterone acetate—Abdominal pain—Galantamine—Alzheimer's disease	0.0012	0.00152	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00118	0.0015	CcSEcCtD
Cyproterone acetate—Anaemia—Rivastigmine—Alzheimer's disease	0.00118	0.00149	CcSEcCtD
Cyproterone acetate—Malaise—Memantine—Alzheimer's disease	0.00118	0.00149	CcSEcCtD
Cyproterone acetate—Agitation—Rivastigmine—Alzheimer's disease	0.00117	0.00149	CcSEcCtD
Cyproterone acetate—Oedema—Donepezil—Alzheimer's disease	0.00117	0.00149	CcSEcCtD
Cyproterone acetate—Syncope—Memantine—Alzheimer's disease	0.00117	0.00148	CcSEcCtD
Cyproterone acetate—Leukopenia—Memantine—Alzheimer's disease	0.00117	0.00148	CcSEcCtD
Cyproterone acetate—Shock—Donepezil—Alzheimer's disease	0.00115	0.00146	CcSEcCtD
Cyproterone acetate—Malaise—Rivastigmine—Alzheimer's disease	0.00115	0.00146	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Donepezil—Alzheimer's disease	0.00115	0.00146	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Memantine—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Cyproterone acetate—Syncope—Rivastigmine—Alzheimer's disease	0.00115	0.00145	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00114	0.00563	CbGpPWpGaD
Cyproterone acetate—Cough—Memantine—Alzheimer's disease	0.00114	0.00144	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—APP—Alzheimer's disease	0.00114	0.00561	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00113	0.00144	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00112	0.00142	CcSEcCtD
Cyproterone acetate—Anorexia—Donepezil—Alzheimer's disease	0.00112	0.00142	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—NOTCH1—Alzheimer's disease	0.00112	0.00552	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Galantamine—Alzheimer's disease	0.00112	0.00141	CcSEcCtD
Cyproterone acetate—Cough—Rivastigmine—Alzheimer's disease	0.00111	0.00141	CcSEcCtD
Cyproterone acetate—Discomfort—Memantine—Alzheimer's disease	0.0011	0.00139	CcSEcCtD
Cyproterone acetate—Hypotension—Donepezil—Alzheimer's disease	0.0011	0.00139	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—INS—Alzheimer's disease	0.00109	0.00538	CbGpPWpGaD
Cyproterone acetate—Asthenia—Galantamine—Alzheimer's disease	0.00109	0.00138	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.00108	0.00535	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00108	0.00137	CcSEcCtD
Cyproterone acetate—Discomfort—Rivastigmine—Alzheimer's disease	0.00107	0.00136	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00107	0.0053	CbGpPWpGaD
Cyproterone acetate—Oedema—Memantine—Alzheimer's disease	0.00107	0.00135	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—PPARGC1A—Alzheimer's disease	0.00106	0.00524	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00105	0.0052	CbGpPWpGaD
Cyproterone acetate—Shock—Memantine—Alzheimer's disease	0.00105	0.00133	CcSEcCtD
Cyproterone acetate—Dyspnoea—Donepezil—Alzheimer's disease	0.00105	0.00132	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Memantine—Alzheimer's disease	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Memantine—Alzheimer's disease	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—Oedema—Rivastigmine—Alzheimer's disease	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—Tachycardia—Memantine—Alzheimer's disease	0.00104	0.00132	CcSEcCtD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—Alzheimer's disease	0.00104	0.00513	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—ESR1—Alzheimer's disease	0.00104	0.00513	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Galantamine—Alzheimer's disease	0.00104	0.00131	CcSEcCtD
Cyproterone acetate—Skin disorder—Memantine—Alzheimer's disease	0.00103	0.00131	CcSEcCtD
Cyproterone acetate—Dyspepsia—Donepezil—Alzheimer's disease	0.00103	0.00131	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Memantine—Alzheimer's disease	0.00103	0.0013	CcSEcCtD
Cyproterone acetate—Shock—Rivastigmine—Alzheimer's disease	0.00103	0.0013	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Cyproterone acetate—Decreased appetite—Donepezil—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00102	0.00503	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00102	0.00503	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Rivastigmine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Cyproterone acetate—Anorexia—Memantine—Alzheimer's disease	0.00102	0.00129	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00101	0.00128	CcSEcCtD
Cyproterone acetate—Skin disorder—Rivastigmine—Alzheimer's disease	0.00101	0.00128	CcSEcCtD
Cyproterone acetate—Fatigue—Donepezil—Alzheimer's disease	0.00101	0.00128	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00101	0.00128	CcSEcCtD
Cyproterone acetate—Constipation—Donepezil—Alzheimer's disease	0.001	0.00127	CcSEcCtD
Cyproterone acetate—Dizziness—Galantamine—Alzheimer's disease	0.001	0.00127	CcSEcCtD
Cyproterone acetate—Hypotension—Memantine—Alzheimer's disease	0.000995	0.00126	CcSEcCtD
Cyproterone acetate—Anorexia—Rivastigmine—Alzheimer's disease	0.000993	0.00126	CcSEcCtD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000988	0.00488	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000986	0.00487	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Alzheimer's disease	0.000985	0.00487	CbGpPWpGaD
Cyproterone acetate—Hypotension—Rivastigmine—Alzheimer's disease	0.000974	0.00123	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000967	0.00122	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000963	0.00475	CbGpPWpGaD
Cyproterone acetate—Vomiting—Galantamine—Alzheimer's disease	0.000963	0.00122	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000959	0.00121	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—MEF2C—Alzheimer's disease	0.000958	0.00473	CbGpPWpGaD
Cyproterone acetate—Rash—Galantamine—Alzheimer's disease	0.000955	0.00121	CcSEcCtD
Cyproterone acetate—Dermatitis—Galantamine—Alzheimer's disease	0.000954	0.00121	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000952	0.0047	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Memantine—Alzheimer's disease	0.00095	0.0012	CcSEcCtD
Cyproterone acetate—Headache—Galantamine—Alzheimer's disease	0.000948	0.0012	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000948	0.00468	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Memantine—Alzheimer's disease	0.000938	0.00119	CcSEcCtD
Cyproterone acetate—Urticaria—Donepezil—Alzheimer's disease	0.000932	0.00118	CcSEcCtD
Cyproterone acetate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000929	0.00118	CcSEcCtD
Cyproterone acetate—Abdominal pain—Donepezil—Alzheimer's disease	0.000927	0.00117	CcSEcCtD
Cyproterone acetate—Body temperature increased—Donepezil—Alzheimer's disease	0.000927	0.00117	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000926	0.00457	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Memantine—Alzheimer's disease	0.000926	0.00117	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00092	0.00116	CcSEcCtD
Cyproterone acetate—Fatigue—Memantine—Alzheimer's disease	0.000918	0.00116	CcSEcCtD
Cyproterone acetate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000917	0.00116	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000913	0.00451	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000912	0.0045	CbGpPWpGaD
Cyproterone acetate—Constipation—Memantine—Alzheimer's disease	0.000911	0.00115	CcSEcCtD
Cyproterone acetate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000906	0.00115	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.0009	0.00114	CcSEcCtD
Cyproterone acetate—Nausea—Galantamine—Alzheimer's disease	0.000899	0.00114	CcSEcCtD
Cyproterone acetate—Fatigue—Rivastigmine—Alzheimer's disease	0.000898	0.00114	CcSEcCtD
Cyproterone acetate—Constipation—Rivastigmine—Alzheimer's disease	0.000891	0.00113	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Memantine—Alzheimer's disease	0.000878	0.00111	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000875	0.00432	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000871	0.0011	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOB—Alzheimer's disease	0.000871	0.0043	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000866	0.00427	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000865	0.00427	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000864	0.00109	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000859	0.00109	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000852	0.00108	CcSEcCtD
Cyproterone acetate—Urticaria—Memantine—Alzheimer's disease	0.000846	0.00107	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000844	0.00417	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Memantine—Alzheimer's disease	0.000842	0.00107	CcSEcCtD
Cyproterone acetate—Body temperature increased—Memantine—Alzheimer's disease	0.000842	0.00107	CcSEcCtD
Cyproterone acetate—Asthenia—Donepezil—Alzheimer's disease	0.000842	0.00107	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00084	0.00415	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000832	0.00411	CbGpPWpGaD
Cyproterone acetate—Pruritus—Donepezil—Alzheimer's disease	0.00083	0.00105	CcSEcCtD
Cyproterone acetate—Urticaria—Rivastigmine—Alzheimer's disease	0.000828	0.00105	CcSEcCtD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000827	0.00408	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000824	0.00104	CcSEcCtD
Cyproterone acetate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000824	0.00104	CcSEcCtD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—ESR1—Alzheimer's disease	0.000821	0.00406	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000819	0.00404	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000814	0.00402	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000813	0.00401	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000805	0.00397	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Donepezil—Alzheimer's disease	0.000803	0.00102	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000799	0.00394	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000791	0.0039	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000791	0.0039	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Memantine—Alzheimer's disease	0.000785	0.000994	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—Alzheimer's disease	0.00078	0.00385	CbGpPWpGaD
Cyproterone acetate—Dizziness—Donepezil—Alzheimer's disease	0.000776	0.000983	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000768	0.000972	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000766	0.00378	CbGpPWpGaD
Cyproterone acetate—Asthenia—Memantine—Alzheimer's disease	0.000764	0.000968	CcSEcCtD
Cyproterone acetate—Pruritus—Memantine—Alzheimer's disease	0.000754	0.000954	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000752	0.00371	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000749	0.0037	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000748	0.00369	CbGpPWpGaD
Cyproterone acetate—Asthenia—Rivastigmine—Alzheimer's disease	0.000748	0.000947	CcSEcCtD
Cyproterone acetate—Vomiting—Donepezil—Alzheimer's disease	0.000746	0.000945	CcSEcCtD
Cyproterone acetate—Rash—Donepezil—Alzheimer's disease	0.00074	0.000937	CcSEcCtD
Cyproterone acetate—Dermatitis—Donepezil—Alzheimer's disease	0.000739	0.000936	CcSEcCtD
Cyproterone acetate—Pruritus—Rivastigmine—Alzheimer's disease	0.000737	0.000934	CcSEcCtD
Cyproterone acetate—Headache—Donepezil—Alzheimer's disease	0.000735	0.000931	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000731	0.00361	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Memantine—Alzheimer's disease	0.000729	0.000923	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—GSK3B—Alzheimer's disease	0.000723	0.00357	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CAV1—Alzheimer's disease	0.00072	0.00355	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000713	0.000903	CcSEcCtD
Cyproterone acetate—Dizziness—Memantine—Alzheimer's disease	0.000704	0.000892	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000703	0.00347	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—BAX—Alzheimer's disease	0.000697	0.00344	CbGpPWpGaD
Cyproterone acetate—Nausea—Donepezil—Alzheimer's disease	0.000697	0.000883	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—CREB1—Alzheimer's disease	0.000696	0.00344	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000692	0.00342	CbGpPWpGaD
Cyproterone acetate—Dizziness—Rivastigmine—Alzheimer's disease	0.000689	0.000873	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000677	0.00334	CbGpPWpGaD
Cyproterone acetate—Vomiting—Memantine—Alzheimer's disease	0.000677	0.000858	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000673	0.00332	CbGpPWpGaD
Cyproterone acetate—Rash—Memantine—Alzheimer's disease	0.000672	0.000851	CcSEcCtD
Cyproterone acetate—Dermatitis—Memantine—Alzheimer's disease	0.000671	0.00085	CcSEcCtD
Cyproterone acetate—Headache—Memantine—Alzheimer's disease	0.000667	0.000845	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000667	0.00329	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000663	0.00328	CbGpPWpGaD
Cyproterone acetate—Vomiting—Rivastigmine—Alzheimer's disease	0.000663	0.000839	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—PTGS1—Alzheimer's disease	0.00066	0.00326	CbGpPWpGaD
Cyproterone acetate—Rash—Rivastigmine—Alzheimer's disease	0.000657	0.000832	CcSEcCtD
Cyproterone acetate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000656	0.000831	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000656	0.00324	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000656	0.00324	CbGpPWpGaD
Cyproterone acetate—Headache—Rivastigmine—Alzheimer's disease	0.000653	0.000827	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000647	0.00319	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000643	0.00317	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000638	0.00315	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ESR1—Alzheimer's disease	0.000638	0.00315	CbGpPWpGaD
Cyproterone acetate—Nausea—Memantine—Alzheimer's disease	0.000633	0.000801	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—NOTCH1—Alzheimer's disease	0.000631	0.00311	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—Alzheimer's disease	0.000629	0.00311	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—GSK3B—Alzheimer's disease	0.000629	0.00311	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—CREB1—Alzheimer's disease	0.000624	0.00308	CbGpPWpGaD
Cyproterone acetate—Nausea—Rivastigmine—Alzheimer's disease	0.000619	0.000784	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000617	0.00305	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000608	0.003	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000607	0.003	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.0006	0.00296	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.0006	0.00296	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00059	0.00291	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.000582	0.00287	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000574	0.00283	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—Alzheimer's disease	0.000567	0.0028	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000567	0.0028	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000564	0.00278	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000561	0.00277	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.00056	0.00277	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—AKT1—Alzheimer's disease	0.000559	0.00276	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000548	0.00271	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARGC1A—Alzheimer's disease	0.000533	0.00263	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000524	0.00259	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.00051	0.00252	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—GSK3B—Alzheimer's disease	0.00051	0.00252	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CREB1—Alzheimer's disease	0.000506	0.0025	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000502	0.00248	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000499	0.00246	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK8—Alzheimer's disease	0.000488	0.00241	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LPL—Alzheimer's disease	0.000486	0.0024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000485	0.00239	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—MEF2C—Alzheimer's disease	0.000481	0.00238	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PHF1—Alzheimer's disease	0.000475	0.00235	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000467	0.00231	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000461	0.00228	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000454	0.00224	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000448	0.00221	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00043	0.00212	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000416	0.00205	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000409	0.00202	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—Alzheimer's disease	0.000407	0.00201	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000398	0.00197	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000397	0.00196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	0.000391	0.00193	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000378	0.00187	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000376	0.00186	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DHCR24—Alzheimer's disease	0.000374	0.00185	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PHF1—Alzheimer's disease	0.000361	0.00178	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	0.000355	0.00175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000352	0.00174	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	0.00035	0.00173	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000349	0.00172	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—INS—Alzheimer's disease	0.000348	0.00172	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	0.000344	0.0017	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000343	0.00169	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000339	0.00167	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	0.000339	0.00167	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—AKT1—Alzheimer's disease	0.000338	0.00167	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	0.000336	0.00166	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000333	0.00165	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000331	0.00163	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000326	0.00161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CA4—Alzheimer's disease	0.000318	0.00157	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000311	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TFAM—Alzheimer's disease	0.000306	0.00151	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.000303	0.00149	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000302	0.00149	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GAPDHS—Alzheimer's disease	0.000299	0.00148	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000296	0.00146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000295	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000295	0.00146	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000284	0.0014	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	0.000283	0.0014	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000272	0.00134	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLD3—Alzheimer's disease	0.00027	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00027	0.00133	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.00027	0.00133	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.00027	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000267	0.00132	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.00026	0.00129	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	0.000259	0.00128	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.000257	0.00127	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000253	0.00125	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.000251	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00025	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—Alzheimer's disease	0.00025	0.00124	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	0.00025	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000249	0.00123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ND1—Alzheimer's disease	0.000241	0.00119	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	0.00024	0.00118	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000236	0.00116	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TFAM—Alzheimer's disease	0.000232	0.00115	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000231	0.00114	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000224	0.00111	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000224	0.0011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.000221	0.00109	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	0.00022	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000215	0.00106	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000214	0.00106	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000213	0.00105	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	0.000205	0.00101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000203	0.001	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000202	0.000995	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000195	0.000964	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.000194	0.000958	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00019	0.000937	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000188	0.000929	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000187	0.000923	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000186	0.000917	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EIF2S1—Alzheimer's disease	0.000184	0.00091	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000182	0.000901	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000181	0.000892	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000173	0.000854	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000171	0.000842	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000169	0.000835	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.000167	0.000824	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.000164	0.000809	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000163	0.000803	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000161	0.000794	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TPI1—Alzheimer's disease	0.000155	0.000767	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CHAT—Alzheimer's disease	0.000155	0.000767	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000152	0.00075	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOB—Alzheimer's disease	0.000149	0.000735	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	0.000143	0.000707	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000142	0.0007	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000142	0.0007	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.000141	0.000696	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.00014	0.000693	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.00014	0.000691	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—A2M—Alzheimer's disease	0.000138	0.000683	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000137	0.000677	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000136	0.00067	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000131	0.000648	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000129	0.000639	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000123	0.000609	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACHE—Alzheimer's disease	0.00012	0.000594	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	0.000119	0.000588	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO1—Alzheimer's disease	0.000113	0.000557	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	0.000113	0.000557	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	0.000111	0.000546	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—Alzheimer's disease	0.000105	0.000518	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	9.9e-05	0.000489	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.71e-05	0.000479	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	9.59e-05	0.000474	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—Alzheimer's disease	9e-05	0.000445	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NOTCH1—Alzheimer's disease	8.7e-05	0.00043	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	8.27e-05	0.000408	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	8.23e-05	0.000406	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARG—Alzheimer's disease	8.21e-05	0.000406	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPL—Alzheimer's disease	7.53e-05	0.000372	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—Alzheimer's disease	6.83e-05	0.000337	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	6.78e-05	0.000335	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	6.6e-05	0.000326	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CALM1—Alzheimer's disease	6.33e-05	0.000313	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—Alzheimer's disease	6.31e-05	0.000312	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—Alzheimer's disease	6.25e-05	0.000309	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARG—Alzheimer's disease	6.23e-05	0.000308	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARG—Alzheimer's disease	5.5e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—Alzheimer's disease	5.39e-05	0.000266	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—Alzheimer's disease	4.73e-05	0.000233	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	4.32e-05	0.000213	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—Alzheimer's disease	3.25e-05	0.00016	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—Alzheimer's disease	2.46e-05	0.000122	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—Alzheimer's disease	2.17e-05	0.000107	CbGpPWpGaD
